SSRI Augmentation Could Increase Remission Rates As First-Line Therapy
Augmentation of selective serotonin reuptake inhibitor initial therapy with another SSRI or other class of antidepressant agent could improve remission rates, authors of a study published in the March 23 New England Journal of Medicine suggested
You may also be interested in...
The Agency for Healthcare Research and Quality is evaluating whether patients with depression experience better outcomes after switching antidepressants, or from addition of a second drug
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011